Here at INDICRO, we have been keeping abreast of the changes occurring across the life sciences industry for all those involved in medical product development. You can find some of the recent highlights on our radar below;

• The MHRA have launched an online eligibility checker tool for applications via the new International Recognition Procedure. Read more here.
• The FDA have issued a final guidance on developing drugs for COVID-19 treatment and prevention. Read more here
• Health Data Research UK (HDR UK) announces new funding to improve transparency of health data access processes for researchers and the public. Read more here
• Thousands to be offered a drug to treat breast cancer in postmenopausal women. Read more here
• Inquiry is exposing deep flaws in Covid decision-making. Pleaseread here and here
• UK biotech sector thrives amidst economic uncertainties. Read more here
• The British Healthcare Trades Association (BHTA) has unveiled its vision for the future of the medtech and life sciences sector in a new manifesto launched this week in Parliament. Read more here
• Freedom of information request shows Biomedical Catalyst is backing only 4% of applications assessed as worthy of funding. Read more here
• After an open competition, the University of Leeds will be the supplier of the NIHR Research Delivery Network Coordinating Centre (RDNCC). Read more here 
• NIHR awards £42m to new centres to develop innovative technology solutions to improve healthcare. Read more here

We will be sharing more industry updates via our blog on a monthly basis. For any queries please contact [email protected]